Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículo Destacado en trastornos del movimiento

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Ataxia

370 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia.

Tezenas du Montcel S, Charles P, Goizet C, Marelli C, Ribai P, Vincitorio C, Anheim M, Guyant-Maréchal L, Le Bayon A, Vandenberghe N, Tchikviladzé M, Devos D, Le Ber I, N'Guyen K, Cazeneuve C, Tallaks

Arch Neurol. 2012 Apr;69(4):500-8. doi: 10.1001/archneurol.2011.2713.

0

0

0

PUBMED

A case of very rapid progressive ataxia in rehabilitation setting.

Gialanella B, Prometti P, Ferlucci C, Bertolinelli M.

Aging Clin Exp Res. 2012 Apr;24(2):197-9.

0

0

0

PUBMED

Cerebellar Ataxia from Multiple Potential Causes: Hypothyroidism, Hashimoto's Thyroiditis, Thalamic Stimulation, and Essential Tremor.

Shneyder N, Lyons MK, Driver-Dunckley E, Evidente VG.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-44-309-2. doi: 10.7916/D8BP01H5.

0

0

0

PUBMED

Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts.

Richardson TE, Yu AE, Wen Y, Yang SH, Simpkins JW.

PLoS One. 2012;7(4):e34600. doi: 10.1371/journal.pone.0034600.

0

0

0

PUBMED

Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies.

Bhandari HS.

BMJ Case Rep. 2012 Aug 8;2012. pii: bcr2012006339. doi: 10.1136/bcr-2012-006339. Review.

0

0

0

PUBMED

Rapidly progressive cognitive impairment, ataxia, and myoclonus: an unusual presentation of a dural arteriovenous fistula.

Geraldes R, Albuquerque L, Ferro JM, Sousa R, Sequeira P, Campos J.

J Stroke Cerebrovasc Dis. 2012 Oct;21(7):619.e3-5. doi: 10.1016/j.jstrokecerebrovasdis.2011.01.002.

0

0

0

PUBMED

Autosomal-recessive congenital cerebellar ataxia is caused by mutations in metabotropic glutamate receptor 1.

Guergueltcheva V, Azmanov DN, Angelicheva D, Smith KR, Chamova T, Florez L, Bynevelt M, Nguyen T, Cherninkova S, Bojinova V, Kaprelyan A, Angelova L, Morar B, Chandler D, Kaneva R, Bahlo M, Tournev I,

Am J Hum Genet. 2012 Sep 7;91(3):553-64. doi: 10.1016/j.ajhg.2012.07.019.

0

0

0

PUBMED

Cardiomyopathy in Friedreich ataxia: exemplifying the challenges faced by cardiologists in the management of rare diseases.

Jensen MK, Bundgaard H.

Circulation. 2012 Apr 3;125(13):1591-3. doi: 10.1161/CIRCULATIONAHA.112.095364. No abstract available.

0

0

0

PUBMED

Neurodegeneration in friedreich's ataxia is associated with a mixed activation pattern of the brain. A fMRI study.

Ginestroni A, Diciotti S, Cecchi P, Pesaresi I, Tessa C, Giannelli M, Della Nave R, Salvatore E, Salvi F, Dotti MT, Piacentini S, Soricelli A, Cosottini M, De Stefano N, Mascalchi M.

Hum Brain Mapp. 2012 Aug;33(8):1780-91. doi: 10.1002/hbm.21319.

0

0

0

PUBMED

A review of Friedreich ataxia clinical trial results.

Perlman SL.

J Child Neurol. 2012 Sep;27(9):1217-22. doi: 10.1177/0883073812453872. Review.

0

0

0

PUBMED

[Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].

Carra-Dalliere C, Thouvenot E, Bonafé A, Ducray F, Touchon J, Charif M.

Rev Neurol (Paris). 2012 Apr;168(4):363-6. doi: 10.1016/j.neurol.2011.07.018. French.

0

0

0

PUBMED

Protein interacting with C kinase (PICK1) is a suppressor of spinocerebellar ataxia 3-associated neurodegeneration in Drosophila.

McGurk L, Bonini NM.

Hum Mol Genet. 2012 Jan 1;21(1):76-84. doi: 10.1093/hmg/ddr439.

0

0

0

PUBMED

Is Friedreich ataxia an epigenetic disorder?

Kumari D, Usdin K.

Clin Epigenetics. 2012 Jan 30;4(1):2. doi: 10.1186/1868-7083-4-2.

0

0

0

PUBMED

New findings in the ataxia of Charlevoix-Saguenay.

Gazulla J, Benavente I, Vela AC, Marín MA, Pablo LE, Tessa A, Barrena MR, Santorelli FM, Nesti C, Modrego P, Tintoré M, Berciano J.

J Neurol. 2012 May;259(5):869-78. doi: 10.1007/s00415-011-6269-5.

0

0

0

PUBMED

Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia.

Soragni E, Xu C, Plasterer HL, Jacques V, Rusche JR, Gottesfeld JM.

J Child Neurol. 2012 Sep;27(9):1164-73. doi: 10.1177/0883073812448533. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy